image of Joseph Bayne
ucsf logo

Joseph Bayne, MD

He | Him | HisCardiology (Adult Congenital Heart Disease) • Cardiology
Cardiology Parnassus
415-353-2873
image of Joseph Bayne
image of Joseph Bayne
ucsf logo

Joseph Bayne, MD

He | Him | HisCardiology (Adult Congenital Heart Disease) • Cardiology
Cardiology Parnassus
415-353-2873

On this page

About me

Dr. Joseph Bayne is a cardiologist who cares for patients with heart disease. He focuses on congenital heart disease (structural defects present at birth) and pulmonary hypertension (increased blood pressure in the arteries of the lungs) and offers particular expertise in interpreting heart imaging results and cardiopulmonary exercise tests. His overarching goal is to help his patients be as healthy as possible.

In his research, Bayne studies the genetic and environmental factors linking congenital heart disease and pulmonary hypertension.

Education

Board Certification

  • Cardiovascular Disease, American Board of Internal Med/Cardiovascular Dis
  • Internal Medicine, American Board of Internal Medicine

Fellowship

  • Adult Congenital Heart Disease, UCSF School of Medicine -GME
  • Cardiovascular Disease, UCSF School of Medicine -GME

Residency

  • Internal Medicine, New York Presbyterian /Columbia GME

School

  • MD, Columbia University College of Physicians and Surgeons

Academic Title

  • Health Sciences Clinical Professor

Care Keywords

  • Services
    • Cardiology (Adult Congenital Heart Disease)
    • Cardiology

Locations

    Provider Research Listing

    Browse clinical trials and publications by this provider

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

    The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.